This review aims to provide insight into the role of
N6-methyladenosine (m6A) modification in neoplastic immunity and subsequent
tumorigenesis.
m6A modification, which is catalyzed by
methyltransferases, demethylases and reader
proteins, has emerged as a widespread regulatory mechanism that controls immune-related gene expression and immune reactions during
tumorigenesis. Aberrant
m6A modification changes the neoplastic immune response in multiple
cancers by regulating immune cell infiltration,
tumor-promoting
inflammation, immunosuppression, immune surveillance, and antitumor immune responses.
m6A modification affects immune cell recruitment and
cancer-promoting
inflammation in
hepatocellular carcinoma (HCC) to alter the progression of HCC.
m6A modification has been implicated in the infiltration of immune cells and the activation of immune pathways, changing the proliferation and
metastasis of
gastric cancer. Immune surveillance and the antitumor immune response in
breast cancer were enhanced via
m6A modification, which inhibited
tumor proliferation.
m6A modification participates in neoplastic immunoregulation to influence
tumor progression.